首页> 外文OA文献 >Anticancer and antiangiogenic activity of surfactant-free nanoparticles based on self-assembled polymeric derivatives of vitamin E: Structure-activity relationship
【2h】

Anticancer and antiangiogenic activity of surfactant-free nanoparticles based on self-assembled polymeric derivatives of vitamin E: Structure-activity relationship

机译:基于维生素E自组装聚合物衍生物的无表面活性剂纳米颗粒的抗癌和抗血管生成活性:构效关系

摘要

¿-Tocopheryl succinate (¿-TOS) is a well-known mitochondrially targeted anticancer compound, however, it is highly hydrophobic and toxic. In order to improve its activity and reduce its toxicity, new surfactant-free biologically active nanoparticles (NP) were synthesized. A methacrylic derivative of ¿-TOS (MTOS) was prepared and incorporated in amphiphilic pseudoblock copolymers when copolymerized with N-vinylpyrrolidone (VP) by free radical polymerization (poly(VP-co-MTOS)). The selected poly(VP-co-MTOS) copolymers formed surfactant-free NP by nanoprecipitation with sizes between 96 and 220 nm and narrow size distribution, and the in vitro biological activity was tested. In order to understand the structure-activity relationship three other methacrylic monomers were synthesized and characterized: MVE did not have the succinate group, SPHY did not have the chromanol ring, and MPHY did not have both the succinate group and the chromanol ring. The corresponding families of copolymers (poly(VP-co-MVE), poly(VP-co-SPHY), and poly(VP-co-MPHY)) were synthesized and characterized, and their biological activity was compared to poly(VP-co-MTOS). Both poly(VP-co-MTOS) and poly(VP-co-MVE) presented triple action: reduced cell viability of cancer cells with little or no harm to normal cells (anticancer), reduced viability of proliferating endothelial cells with little or no harm to quiescent endothelial cells (antiangiogenic), and efficiently encapsulated hydrophobic molecules (nanocarrier). The anticancer and antiangiogenic activity of the synthesized copolymers is demonstrated as the active compound (vitamin E or ¿-tocopheryl succinate) do not need to be cleaved to trigger the biological action targeting ubiquinone binding sites of complex II. Poly(VP-co-SPHY) and poly(VP-co-MPHY) also formed surfactant-free NP that were also endocyted by the assayed cells; however, these NP did not selectively reduce cell viability of cancer cells. Therefore, the chromanol ring of the vitamin E analogues has an important role in the biological activity of the copolymers. Moreover, when succinate moiety is substituted and vitamin E is directly linked to the macromolecular chain through an ester bond, the biological activity is maintained.
机译:??-生育酚琥珀酸酯(?-TOS)是一种众所周知的线粒体靶向抗癌化合物,但是它具有高度的疏水性和毒性。为了提高其活性并降低其毒性,合成了新的不含表面活性剂的生物活性纳米颗粒(NP)。制备了β-TOS(MTOS)的甲基丙烯酸衍生物,并通过自由基聚合与N-乙烯基吡咯烷酮(VP)共聚时,将其掺入两亲性假嵌段共聚物中。所选择的聚(VP-co-MTOS)共聚物通过纳米沉淀法形成无表面活性剂的NP,其粒径在96至220 nm之间,粒径分布窄,并测试了其体外生物学活性。为了理解结构-活性关系,还合成了三种其他甲基丙烯酸单体并进行了表征:MVE不具有琥珀酸酯基,SPHY不具有苯甲酚环,MPHY不具有琥珀酸酯基和苯甲酚环。合成并表征了相应的共聚物家族(聚(VP-co-MVE),聚(VP-co-SPHY)和聚(VP-co-MPHY)),并将它们的生物学活性与聚(VP-co-MVE)进行了比较。 MTOS)。聚(VP-co-MTOS)和聚(VP-co-MVE)均表现出三重作用:癌细胞的细胞活力降低,而对正常细胞(抗癌)几乎没有伤害;内皮细胞增殖的活力降低,而对正常细胞几乎没有伤害对静止的内皮细胞有害(抗血管生成),并有效地包裹疏水分子(纳米载体)。证明了合成共聚物的抗癌和抗血管生成活性,因为不需要裂解活性化合物(维生素E或β-生育酚琥珀酸酯)即可触发针对复合物II的泛醌结合位点的生物作用。聚(VP-co-SPHY)和聚(VP-co-MPHY)也形成了不含表面活性剂的NP,它们也被测定的细胞内吞。然而,这些NP没有选择性地降低癌细胞的细胞活力。因此,维生素E类似物的苯甲酚环在共聚物的生物活性中具有重要作用。此外,当琥珀酸酯部分被取代并且维生素E通过酯键直接连接至大分子链时,保持了生物学活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号